The Role of TRPV4 in Regulating Innate Immune Cell Function in Lung Inflammation

by Rachel G. Scheraga, Rachel G. Scheraga, Brian D. Southern, Brian D. Southern, Lisa M. Grove, Mitchell A. Olman, Mitchell A. Olman
Published 2020-06-01

The Role of Transient Receptor Potential Vanilloid 4 in Pulmonary Inflammatory Diseases

by Rachel G. Scheraga, Brian D. Southern, Lisa M. Grove, Mitchell A. Olman
Published 2017-05-01

Adenosine 2A receptor antagonist prevented and reversed liver fibrosis in a mouse model of ethanol-exacerbated liver fibrosis.

by Dian J Chiang, Sanjoy Roychowdhury, Katelyn Bush, Megan R McMullen, Sorana Pisano, Kathryn Niese, Mitchell A Olman, Michele T Pritchard, Laura E Nagy
Published 2013-01-01

Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohort

by Jamie L. Todd, Richard Vinisko, Yi Liu, Megan L. Neely, Robert Overton, Kevin R. Flaherty, Imre Noth, L. Kristin Newby, Joseph A. Lasky, Mitchell A. Olman, Christian Hesslinger, Thomas B. Leonard, Scott M. Palmer, John A. Belperio, on behalf of the IPF-PRO Registry investigators
Published 2020-03-01

Downregulation of FIP200 induces apoptosis of glioblastoma cells and microvascular endothelial cells by enhancing Pyk2 activity.

by Dongyan Wang, Mitchell A Olman, Jerry Stewart, Russell Tipps, Ping Huang, Paul W Sanders, Eric Toline, Richard A Prayson, Jeongwu Lee, Robert J Weil, Cheryl A Palmer, G Yancey Gillespie, Wei Michael Liu, Russell O Pieper, Jun-Lin Guan, Candece L Gladson
Published 2011-01-01